Jagmohan Hooda, University of Pittsburgh, USA

I was delighted to find that the University of Pittsburgh’s Read & Publish agreement with The Company of Biologists covered our article in Disease Models & Mechanisms. For researchers working on rare and understudied cancers like invasive lobular carcinoma, Open Access publishing ensures our work reaches the widest possible audience, from clinicians and basic scientists to patient advocates, without financial barriers. This kind of institutional support makes a real difference and I am truly grateful for it.